Clinical and Biological Predictors of Outcome Following Relapse of Chronic Myeloid Leukemia after Allogeneic Stem Cell

Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: early transplantation, use of an unrelated donor, and chronic graft-versus-host disease are protective

Enright, H
Davies, SM
DeFor, T
Shu, X
Weisdorf, D
Miller, W
Ramsay, NK
Arthur, D
Verfaillie, Catherine
Miller, J
Kersey, J
McGlave, P

July 1996

We analyzed the incidence of posttransplant chronic myelogenous leukemia (CML) relapse in 283 consec...

Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?

Radujkovic, Aleksandar
Guglielmi, Cesare
Bergantini, Stefania
Iacobelli, Simona
van Biezen, Anja
Milojkovic, Dragana
Gratwohl, Alois
Schattenberg, Antonius V.M.B.
Verdonck, Leo F.
Niederwieser, Dietger W.
de Witte, Theo
Kröger, Nicolaus
Olavarria, Eduardo

July 2015

AbstractDonor lymphocyte infusions (DLI) are an effective treatment for relapsed chronic myeloid leu...

Chronic Myeloid Leukemia Relapsing 25 Years after Allogenic Stem Cell Transplantation

Håkon Reikvam
Jørn Skavland
Stein-Erik Gullaksen
Randi Hovland
Tobias Gedde-Dahl
Øystein Bruserud
Bjørn Tore Gjertsen

January 2018

Chronic myeloid leukemia (CML) is a myeloproliferative disorder in which neoplastic cells exhibit th...

Clinical and biological predictors of outcome following relapse of CML post-allo-SCT

Jain, N.
Ito, S.
Tian, X.
Kurlander, R.
Battiwalla, M.
Lu, K.
Savani, B.
Malkovska, V.
Rezvani, K.
Le, R.
Shenoy, A.
Hourigan, C.
Keyvanfar, K.
Koklanaris, E.
Superata, J.
Muranski, P.
Barrett, A.
Yong, A.

January 2014

Although there are now fewer allo-SCTs performed for CML, leukemic relapse post transplant remains a...

Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation Group.

W. Arcese
J.M. Goldman
E. D'Arcangelo
A. Schattenberg
A. Nardi
J.F. Apperley
F. Frassoni
H.G. Prentice
P. Ljungman
AVERSA, Franco

January 1993

We studied the clinical course of 130 chronic myeloid leukemia (CML) patients (89 males and 41 femal...

Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse

Mughal, T. I.
Yong, A.
Szydlo, R. M.
Dazzi, F.
Olavarria, E.
Van Rhee, F.
Kaeda, J.
Cross, N. C.
Craddock, C.
Kanfer, E.
Apperley, J.
Goldman, J. M.

January 2001

We identified 103 consecutive patients who, 5 years after allogeneic transplantation for chronic mye...

Survival of patients with PH+ Chronic myeloid leukemia relapsing after an allogeneic stem cell transplant.

Arcese, W
Guglielmi,C

January 2000

Allogeneic blood or marrow stem cell transplantation (SCT) from an HLA-identical sibling is the tre...

Risk assessment in patients with Ph+ chronic myelogenous leukemia at first relapse after allogeneic stem cell transplant: an EBMT retrospective analysis. The Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Guglielmi, C
Hermans, J
Bacigalupo, A
Bandini, G
Bunjes, D
Carreras, E
Devergie, A
Frassoni, F
Goldman, J
Gratwohl, A
Kolb, H
Iori, A
Niederwieser, D
Prentice, H
de Witte, T
Apperley, J.
ARCESE, WILLIAM

June 2000

Patients with Ph+ chronic myelogenous leukemia who relapse after a first allogeneic stem cell transp...

Donor lymphocyte infusions for chronic myeloid leukemia relapsing after allogeneic stem cell transplantation. may we predict graft-versus-leukemia without graft-versus-host disease?

Radujkovic, Aleksandar
Guglielmi, Cesare
Bergantini, Stefania
Iacobelli, Simona
van Biezen, Anja
Milojkovic, Dragana
Gratwohl, Alois
Schattenberg, Antonius V. M. B.
Verdonck, Leo F.
Niederwieser, Dietger W.
de Witte, Theo
Kröger, Nicolaus
Olavarria, Eduardo

January 2015

Donor lymphocyte infusions (DLI) are an effective treatment for relapsed chronic myeloid leukemia (C...

Achievement of complete remission predicts outcome of allogeneic haematopoietic stem cell transplantation in patients with chronic myelomonocytic leukaemia. A study of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation

Symeonidis, Argiris
van Biezen, Anja
de Wreede, Liesbeth
Piciocchi, Alfonso
Finke, Juergen
Beelen, Dietrich
Bornhäuser, Martin
Cornelissen, Jan
Volin, Liisa
Mufti, Ghulam
Chalandon, Yves
Ganser, Arnold
Bruno, Benedetto
Niederwieser, Dietger
Kobbe, Guido
Schwerdtfeger, Rainer
de Witte, Theo
Robin, Marie
Kröger, Nicolaus
Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation

January 2015

The results of allogeneic stem cell transplantation (allo-SCT) in chronic myelomonocytic leukaemia (...

Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?

Radujkovic, A.
Guglielmi, C.
Bergantini, S.
Iacobelli, S.
Biezen, A. van
Milojkovic, D.
Gratwohl, A.
Schattenberg, A.V.M.B.
Verdonck, L.F.
Niederwieser, D.W.
Witte, T. de
Kroger, N.
Olavarria, E.
Chronic Malignancies Working Party

July 2015

Development and application of statistical models for medical scientific researc

Qin Huang
Marilyn L. Slovak
Karl K. Gaal
Joycelynne M. Palmer
Lawrence M. Weiss

September 2016

Chronic myeloid leukemia (CML) is a myeloproliferative disease that originates in an abnormal plurip...

Clinical and pathologic analysis of 16 cases of relapsed chronic myeloid leukemia after stem cell transplantation

Huang, Qin
Wu, Yaping
Snyder, David S.
Chang, Karen L.
Slovak, Marilyn L.
Gaal, Karl K.
Palmer, Joycelynne M.
Weiss, Lawrence M.

October 2007

Chronic myeloid leukemia (CML) is a myeloproliferative disease that originates in an abnormal plurip...

Late Mortality and Relapse following BuCy2 and HLA-Identical Sibling Marrow Transplantation for Chronic Myelogenous Leukemia

Copelan, Edward A.
Crilley, Pamela Ann
Szer, Jeffrey
Dodds, Anthony J.
Stevenson, Dustin
Phillips, Gary
Elder, Patrick
Nivison-Smith, Ian
Avalos, Belinda R.
Penza, Sam
Topolsky, David
Sobecks, Ronald
Kalaycio, Matt
Bolwell, Brian J.

July 2009

Allogeneic hematopoietic stem cell transplantation (HSCT) is the only known curative therapy for chr...

Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia following allogeneic stem cell transplantation: a retrospective registry analysis on 698 patients by the Chronic Malignancies Working Party of the European Society of Blood and Marrow Transplantation

Schmid, Christoph
Wreede, Liesbeth C.,
Biezen, Anja,
Finke, Juergen
Ehninger, Gerhard
Ganser, Arnold
Volin, Liisa
Niederwieser, Dietger
Beelen, Dietrich
Alessandrino, Paolo
Kanz, Lothar
Schleuning, Michael
Passweg, Jakob
Veelken, Hendrik
Maertens, Johan
Cornelissen, Jan J.
Blaise, Didier
Gramatzki, Martin
Milpied, Noel
Yakoub-Agha, Ibrahim
Mufti, Ghulam
Rovira, Montserrat
Arnold, Renate
Witte, Theo,
Robin, Marie
Kroeger, Nikolaus

January 2018

No standard exists for the treatment of myelodysplastic syndrome relapsing after allogeneic stem cel...

Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: early transplantation, use of an unrelated donor, and chronic graft-versus-host disease are protective

Enright, H
Davies, SM
DeFor, T
Shu, X
Weisdorf, D
Miller, W
Ramsay, NK
Arthur, D
Verfaillie, Catherine
Miller, J
Kersey, J
McGlave, P

July 1996

We analyzed the incidence of posttransplant chronic myelogenous leukemia (CML) relapse in 283 consec...

Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?

Radujkovic, Aleksandar
Guglielmi, Cesare
Bergantini, Stefania
Iacobelli, Simona
van Biezen, Anja
Milojkovic, Dragana
Gratwohl, Alois
Schattenberg, Antonius V.M.B.
Verdonck, Leo F.
Niederwieser, Dietger W.
de Witte, Theo
Kröger, Nicolaus
Olavarria, Eduardo

July 2015

AbstractDonor lymphocyte infusions (DLI) are an effective treatment for relapsed chronic myeloid leu...

Chronic Myeloid Leukemia Relapsing 25 Years after Allogenic Stem Cell Transplantation

Håkon Reikvam
Jørn Skavland
Stein-Erik Gullaksen
Randi Hovland
Tobias Gedde-Dahl
Øystein Bruserud
Bjørn Tore Gjertsen

January 2018

Chronic myeloid leukemia (CML) is a myeloproliferative disorder in which neoplastic cells exhibit th...

Clinical and biological predictors of outcome following relapse of CML post-allo-SCT

Jain, N.
Ito, S.
Tian, X.
Kurlander, R.
Battiwalla, M.
Lu, K.
Savani, B.
Malkovska, V.
Rezvani, K.
Le, R.
Shenoy, A.
Hourigan, C.
Keyvanfar, K.
Koklanaris, E.
Superata, J.
Muranski, P.
Barrett, A.
Yong, A.

January 2014

Although there are now fewer allo-SCTs performed for CML, leukemic relapse post transplant remains a...

Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation Group.

W. Arcese
J.M. Goldman
E. D'Arcangelo
A. Schattenberg
A. Nardi
J.F. Apperley
F. Frassoni
H.G. Prentice
P. Ljungman
AVERSA, Franco

January 1993

We studied the clinical course of 130 chronic myeloid leukemia (CML) patients (89 males and 41 femal...

Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse

Mughal, T. I.
Yong, A.
Szydlo, R. M.
Dazzi, F.
Olavarria, E.
Van Rhee, F.
Kaeda, J.
Cross, N. C.
Craddock, C.
Kanfer, E.
Apperley, J.
Goldman, J. M.

January 2001

We identified 103 consecutive patients who, 5 years after allogeneic transplantation for chronic mye...

Survival of patients with PH+ Chronic myeloid leukemia relapsing after an allogeneic stem cell transplant.

Arcese, W
Guglielmi,C

January 2000

Allogeneic blood or marrow stem cell transplantation (SCT) from an HLA-identical sibling is the tre...

Risk assessment in patients with Ph+ chronic myelogenous leukemia at first relapse after allogeneic stem cell transplant: an EBMT retrospective analysis. The Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Guglielmi, C
Hermans, J
Bacigalupo, A
Bandini, G
Bunjes, D
Carreras, E
Devergie, A
Frassoni, F
Goldman, J
Gratwohl, A
Kolb, H
Iori, A
Niederwieser, D
Prentice, H
de Witte, T
Apperley, J.
ARCESE, WILLIAM

June 2000

Patients with Ph+ chronic myelogenous leukemia who relapse after a first allogeneic stem cell transp...

Donor lymphocyte infusions for chronic myeloid leukemia relapsing after allogeneic stem cell transplantation. may we predict graft-versus-leukemia without graft-versus-host disease?

Radujkovic, Aleksandar
Guglielmi, Cesare
Bergantini, Stefania
Iacobelli, Simona
van Biezen, Anja
Milojkovic, Dragana
Gratwohl, Alois
Schattenberg, Antonius V. M. B.
Verdonck, Leo F.
Niederwieser, Dietger W.
de Witte, Theo
Kröger, Nicolaus
Olavarria, Eduardo

January 2015

Donor lymphocyte infusions (DLI) are an effective treatment for relapsed chronic myeloid leukemia (C...

Achievement of complete remission predicts outcome of allogeneic haematopoietic stem cell transplantation in patients with chronic myelomonocytic leukaemia. A study of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation

Symeonidis, Argiris
van Biezen, Anja
de Wreede, Liesbeth
Piciocchi, Alfonso
Finke, Juergen
Beelen, Dietrich
Bornhäuser, Martin
Cornelissen, Jan
Volin, Liisa
Mufti, Ghulam
Chalandon, Yves
Ganser, Arnold
Bruno, Benedetto
Niederwieser, Dietger
Kobbe, Guido
Schwerdtfeger, Rainer
de Witte, Theo
Robin, Marie
Kröger, Nicolaus
Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation

January 2015

The results of allogeneic stem cell transplantation (allo-SCT) in chronic myelomonocytic leukaemia (...

Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?

Radujkovic, A.
Guglielmi, C.
Bergantini, S.
Iacobelli, S.
Biezen, A. van
Milojkovic, D.
Gratwohl, A.
Schattenberg, A.V.M.B.
Verdonck, L.F.
Niederwieser, D.W.
Witte, T. de
Kroger, N.
Olavarria, E.
Chronic Malignancies Working Party

July 2015

Development and application of statistical models for medical scientific researc

Qin Huang
Marilyn L. Slovak
Karl K. Gaal
Joycelynne M. Palmer
Lawrence M. Weiss

September 2016

Chronic myeloid leukemia (CML) is a myeloproliferative disease that originates in an abnormal plurip...

Clinical and pathologic analysis of 16 cases of relapsed chronic myeloid leukemia after stem cell transplantation

Huang, Qin
Wu, Yaping
Snyder, David S.
Chang, Karen L.
Slovak, Marilyn L.
Gaal, Karl K.
Palmer, Joycelynne M.
Weiss, Lawrence M.

October 2007

Chronic myeloid leukemia (CML) is a myeloproliferative disease that originates in an abnormal plurip...

Late Mortality and Relapse following BuCy2 and HLA-Identical Sibling Marrow Transplantation for Chronic Myelogenous Leukemia

Copelan, Edward A.
Crilley, Pamela Ann
Szer, Jeffrey
Dodds, Anthony J.
Stevenson, Dustin
Phillips, Gary
Elder, Patrick
Nivison-Smith, Ian
Avalos, Belinda R.
Penza, Sam
Topolsky, David
Sobecks, Ronald
Kalaycio, Matt
Bolwell, Brian J.

July 2009

Allogeneic hematopoietic stem cell transplantation (HSCT) is the only known curative therapy for chr...

Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia following allogeneic stem cell transplantation: a retrospective registry analysis on 698 patients by the Chronic Malignancies Working Party of the European Society of Blood and Marrow Transplantation

Schmid, Christoph
Wreede, Liesbeth C.,
Biezen, Anja,
Finke, Juergen
Ehninger, Gerhard
Ganser, Arnold
Volin, Liisa
Niederwieser, Dietger
Beelen, Dietrich
Alessandrino, Paolo
Kanz, Lothar
Schleuning, Michael
Passweg, Jakob
Veelken, Hendrik
Maertens, Johan
Cornelissen, Jan J.
Blaise, Didier
Gramatzki, Martin
Milpied, Noel
Yakoub-Agha, Ibrahim
Mufti, Ghulam
Rovira, Montserrat
Arnold, Renate
Witte, Theo,
Robin, Marie
Kroeger, Nikolaus

January 2018

No standard exists for the treatment of myelodysplastic syndrome relapsing after allogeneic stem cel...

Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: early transplantation, use of an unrelated donor, and chronic graft-versus-host disease are protective

Enright, H
Davies, SM
DeFor, T
Shu, X
Weisdorf, D
Miller, W
Ramsay, NK
Arthur, D
Verfaillie, Catherine
Miller, J
Kersey, J
McGlave, P

July 1996

We analyzed the incidence of posttransplant chronic myelogenous leukemia (CML) relapse in 283 consec...

Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?

Radujkovic, Aleksandar
Guglielmi, Cesare
Bergantini, Stefania
Iacobelli, Simona
van Biezen, Anja
Milojkovic, Dragana
Gratwohl, Alois
Schattenberg, Antonius V.M.B.
Verdonck, Leo F.
Niederwieser, Dietger W.
de Witte, Theo
Kröger, Nicolaus
Olavarria, Eduardo

July 2015

AbstractDonor lymphocyte infusions (DLI) are an effective treatment for relapsed chronic myeloid leu...

Chronic Myeloid Leukemia Relapsing 25 Years after Allogenic Stem Cell Transplantation

Håkon Reikvam
Jørn Skavland
Stein-Erik Gullaksen
Randi Hovland
Tobias Gedde-Dahl
Øystein Bruserud
Bjørn Tore Gjertsen

January 2018

Chronic myeloid leukemia (CML) is a myeloproliferative disorder in which neoplastic cells exhibit th...

Clinical and Biological Predictors of Outcome Following Relapse of Chronic Myeloid Leukemia after Allogeneic Stem Cell

Abstract

Extracted data

Clinical and Biological Predictors of Outcome Following Relapse of Chronic Myeloid Leukemia after Allogeneic Stem Cell

Abstract

Extracted data

Related items

Related items